|
Variable
|
Points
|
|---|
|
ECOG performance status
| |
|
0
|
2
|
|
1
|
0
|
|
≥ 2
|
3
|
|
DLCO (%)
| |
|
> 132
|
0
|
|
118–132
|
1
|
|
102–117
|
2
|
|
87–101
|
3
|
|
72–86
|
4
|
|
56–71
|
5
|
|
41–55
|
6
|
|
26–40
|
7
|
|
< 26
|
8
|
|
Histological diagnosis
| |
|
Squamous cell carcinoma
|
3
|
|
Adenocarcinoma
|
0
|
|
Other
|
1
|
|
Tumour lobe
| |
|
Upper
|
0
|
|
Middle/lower
|
2
|
|
EQD2
| |
|
> 85
|
0
|
|
77–85
|
1
|
|
68–76
|
2
|
|
59–67
|
3
|
|
50–58
|
4
|
|
41–49
|
5
|
|
32–40
|
6
|
|
23–31
|
7
|
|
14–22
|
8
|
|
5–13
|
9
|
|
< 5
|
10
|
|
Risk group
| |
|
1
|
< 10
|
|
2
|
10–15
|
|
3
|
> 15
|
- SWSM = South West Sydney Model; ECOG = Eastern Cooperative Oncology Group; DLCO = diffusing capacity of the lung for carbon monoxide; EQD2 = equivalent dose in 2 Gy fractions
